Please use this identifier to cite or link to this item:
http://20.193.157.4:9595/xmlui/handle/123456789/1152Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Rohith M, MM Angadi | - |
| dc.date.accessioned | 2019-11-06T11:21:44Z | - |
| dc.date.available | 2019-11-06T11:21:44Z | - |
| dc.date.issued | 2016 | - |
| dc.identifier.issn | 23202831 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/1152 | - |
| dc.description.abstract | Lymphatic filariasis is caused by Wucheria brancrofti. The infection is endemic in more than 80 countries, with more than 1.3 billion people at risk and 120 mi llion already infected globally. Mass drug administration (MDA), for control of filariasis was launched by government of India in 1996. Under this programme, all the beneficiaries in the age group of 2 to 60 years (excluding pregnant mothers, people above 60 and having other illness), will be administered. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | BLDE(Deemed to be University) | en_US |
| dc.subject | Mass Drug Administration, Coverage, Compliance | en_US |
| dc.title | Coverage and compliance of mass drug administration for elimination of lymphatic filariasis in endemic areas of Bidar district, Karnataka. | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Faculty of Community Medicine | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.